Clarify Health

MARCH 19, 2024

At the forefront of this revolution is the rising use of various types of healthcare provider data and deep analytics to assess provider performance and build cost-effective, quality networks. According to the National Academy of Medicine , quality healthcare involves many characteristics, including effectiveness, timeliness, and efficiency.

Networking 52

Networking Healthcare Healthcare Healthcare Provider 52

PharmaTech

FEBRUARY 2, 2024

The agency will coordinate intra-regional medicines regulation to strengthen the African regulatory network.

Medicine 52

Medicine Networking 52

Fierce Pharma

NOVEMBER 28, 2023

. | Monday, during the first meeting of the new White House Council on Supply Chain Resilience, President Biden unveiled nearly 30 actions to bolster production networks across industries.

Manufacturing 232

Manufacturing Networking Medicine 232

Legacy MEDSearch

DECEMBER 7, 2022

Medical device and technology company Lazurite has received recognition from Medical Device Network Excellence Awards & Rankings, one of the largest, most prestigious, and widely recognized programs in the industry. All Commended companies will be entered into the Medical Device Network Awards at the end of the year. “The

Networking 98

Networking Medical Food and Drug Administration Recruitment 98

European Pharmaceutical Review

JUNE 14, 2023

To be a superpower globally, the UK life sciences sector must not only discover and develop medicines of the future domestically, but also manufacture a significant share in the country too, according to a new report from the Medicines Manufacturing Industry Partnership (MMIP). It provides almost 45 percent of the £36.9

Medicine 52

Medicine Manufacturing Government Competition 52

European Pharmaceutical Review

AUGUST 23, 2022

FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. Some, 250,000 child deaths per year can be attributed to counterfeit malaria and pneumonia medicines. The prevalence of fake drugs is a continually growing problem worldwide.

Medicine 91

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 91

Legacy MEDSearch

FEBRUARY 28, 2023

Study principal investigator Michel Azizi, Professor of Medicine at Université Paris Cité, Hôpital Européen Georges Pompidou, Paris, France, added, “The pooled analysis of RADIANCE SOLO, TRIO, and RADIANCE II shows a remarkable consistency of effect in patients with mild to moderate hypertension and those with resistant hypertension.

Networking 98

Networking Medical Physicians Safety 98

European Pharmaceutical Review

JULY 20, 2022

Our research paper, which is being submitted for publication this summer, aims to create an evidence-based medicine (EBM) methodology that can assess this positive impact, to further help regulators determine appropriate risk minimisation measures. ketoconazole – an antifungal medicine. Supporting regulators.

Medicine 79

Medicine Safety Side effects Electronics 79

PM360

AUGUST 21, 2023

Digital Health Networks announced its lineup of features and audio storytelling for the Cinehealth International Health and Wellness Film and Video Festival. This year’s festival takes place live in Philadelphia at Digital Pharma East on September 12 th , followed by a virtual segment at Digital Health Networks ( www.dhn.tv ).

Networking 40

Networking Doctors Media Management 40

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Prostate Cancer. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.

Medicine 40

Medicine Distribution Pharmaceutical products Networking 40

Clarify Health

NOVEMBER 1, 2019

Designing and maintaining a high-performing provider network is difficult; not because there is a shortage of great providers practicing medicine in caring, cost-effective, and patient-centric ways. Rather, it’s a lack of clear visibility into provider performance and an ever-changing definition of “high value.”

Networking 52

Networking Medicine Patients 52

European Pharmaceutical Review

DECEMBER 19, 2023

The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) have published a plan, which sets out a “collaborative and coordinated strategy” to maximise the benefits of artificial intelligence in regulation. The plan was prepared by the Big Data Steering Group (BDSG), a joint initiative between HMA and EMA.

Pharma 90

Pharma Networking Medicine Ethics 90

pharmaphorum

FEBRUARY 2, 2024

The PM Society are delighted to be running their fifth Careers Conference that will be taking place on the 21st of February 2024 between 1pm to 6pm at the Royal Society of Medicine. Please share with your colleagues and network, as this is a great opportunity for students to attend and learn more about our industry.

Networking 88

Networking Medicine 88

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Liver Failure (Hepatic Insufficiency). The company offers products through its sales and distribution network in China, the US, Japan, Germany Switzerland, and Australia. It is formulated as tablets for oral route of administration.

Medicine 40

Medicine Distribution Pharmaceutical products Networking 40

European Pharmaceutical Review

MARCH 21, 2024

million strategic initiative is set to support UK advanced therapy medicinal product (ATMP) clinical trials, and help the region maintain its position as a leader in clinical research. An additional four years of funding for the Advanced Therapy Treatment Centre ( ATTC ) network is available through this programme.

Networking 92

Networking Medicine Medical Pharmaceutical 92

MedCity News

OCTOBER 19, 2023

With its new handheld ultrasound device, Exo is seeking to take point-of-care ultrasound beyond just the emergency medicine field — into areas like urgent care, primary care and the home.

Networking 114

Networking Medicine Medical Healthcare 114

pharmaphorum

JANUARY 26, 2023

In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF). It builds on the Cancer Drugs Fund (CDF), an early access mechanism for many cancer medicines in England. The issue is landing the medicine in the NHS.

Medicine 57

Medicine Patients Management Marketing 57

pharmaphorum

FEBRUARY 28, 2024

Ginkgo Bioworks builds its drug discovery toolkit again, making three acquisitions and launching a partner network in AI, genetic medicines, manufacturing and other areas

Networking 60

Networking Manufacturing Medicine 60

Clarify Health

NOVEMBER 1, 2019

Designing and maintaining a high-performing provider network is difficult; not because there is a shortage of great providers practicing medicine in caring, cost-effective, and patient-centric ways. This is akin to adding providers to your network without reliable data. Is that worth the price?

Networking 52

Networking Retail Insurance Patients 52

European Pharmaceutical Review

DECEMBER 7, 2023

A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.

Networking 83

Networking Medicine Leads Manufacturing 83

PharmExec

FEBRUARY 5, 2024

By capitalizing on AI advancements, pushing the boundaries of personalized medicine with theranostics, and strengthening digital healthcare networks, radiopharmaceuticals are poised to transform healthcare from a reactive to a proactive discipline.

Healthcare 52

Healthcare Healthcare Networking Medicine 52

European Pharmaceutical Review

AUGUST 1, 2022

The joint Big Data Steering Group of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) has published a third workplan, setting actions to be delivered by 2025. According to EMA, the new plan will further enhance the efficient integration of data analysis into the regulatory evaluation of medicinal products.

Medicine 90

Medicine Networking Electronics Healthcare 90

Pharmaceutical Technology

FEBRUARY 19, 2023

Camrelizumab is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Solid Tumor. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.

Medicine 40

Medicine Distribution Pharmaceutical products Networking 40

European Pharmaceutical Review

FEBRUARY 8, 2024

Vertex scores European cystic fibrosis medicine approval Efficacy of the vanzacaftor/tezacaftor/deutivacaftor (vanza triple) Vertex also shared that in the SKYLINE 102 and SKYLINE 103 , head-to-head against TRIKAFTA, for first key secondary endpoint, the vanza triple was found to be superior in reducing sweat chloride (SwCl) levels.

Food and Drug Administration 88

Food and Drug Administration Medicine Medical Consulting 88

European Pharmaceutical Review

APRIL 4, 2024

The scheme aims to support UK advanced therapy medicinal product (ATMP) clinical trials. Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. What key solutions will the investment in the Advanced Therapy Treatment Centre Network provide?

Networking 84

Networking Training Recruitment Healthcare 84

European Pharmaceutical Review

APRIL 28, 2023

The network aims to build a comprehensive contextual understanding of situational data in each National Hub to identify opportunities to address existing gaps and challenges. Each hub has specific and complementary multidisciplinary research expertise.

Networking 90

Networking Medicine Leads Pharmaceutical 90

European Pharmaceutical Review

MARCH 20, 2024

The transaction will create “a significant West Coast commercial manufacturing presence, complementing Lonza’s existing Biologics site on the East Coast, in Portsmouth (US), as well as its international network across Europe and Asia”, Lonza shared.

Manufacturing 94

Manufacturing Medicine Networking Pharmaceutical 94

Pharmaceutical Technology

MARCH 10, 2023

Sandoz, a division of Novartis , has signed a Memorandum of Understanding (MoU) for constructing a new biologics production plant in Lendava, Slovenia, to support the growing demand for biosimilar medicines worldwide. At Sandoz, we are determined to continue leading the way in driving access to these critical medicines.

Food and Drug Administration 52

Food and Drug Administration Networking Medicine Food 52

European Pharmaceutical Review

MAY 10, 2023

Dr Florian Bieber, Development Platform Head, Biopharmaceuticals, and Chief Medical Officer of Sandoz stated that investment will help to position the site as part of a “growing network of BioTD centres.” These conditions include rheumatic diseases, Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and hidradenitis suppurativa.

Manufacturing 81

Manufacturing Networking Medicine Biopharma 81

Eversana Intouch

NOVEMBER 16, 2023

The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare. Last week, Frontiers Health, the premier global digital health innovation event, was held in Rome, Italy.

Healthcare 88

Healthcare Healthcare Medicine Pharma 88

Pharma Leaders

MARCH 29, 2023

The European Medicines Agency (EMA) reported “remarkable” progress despite the pandemic in a mid-point assessment of its “Regulatory Science Strategy to 2025” to build a more adaptive regulatory system that will encourage innovation — including advances in clinical trials and a new real-world data (RWD) network.

Networking 52

Networking Medicine Patients 52

European Pharmaceutical Review

NOVEMBER 2, 2022

The clinic will develop pre-clinical studies into early and late phase clinical trials to identify US Food and Drug Administration (FDA)-approved advanced regenerative medicines. The Cedars-Sinai Board of Governors Regenerative Medicine Institute and the Smidt Heart Institute will lead the project. Scientific and operational teams.

Food and Drug Administration 84

Food and Drug Administration Medicine Training Electronics 84

European Pharmaceutical Review

DECEMBER 14, 2023

Decisions to remove medicines from market are not taken lightly and are often based upon all evidence available to inform a benefit/risk balance. Article (Samantha Lane): How can evidence-based medicine (EBM) methodology support drug withdrawals? A rich resource These health records can be a rich text for researchers. 2018; 8(1).

Safety 112

Safety Medicine Competition Networking 112

European Pharmaceutical Review

NOVEMBER 20, 2023

Supporting European parenteral manufacture and supply Alongside expanding the company’s global parenteral product and device manufacturing network, the new facility will support the higher demand for Eli Lilly’s medicines, including its diabetes and obesity portfolio.

Manufacturing 83

Manufacturing Medicine Biopharma Engineering 83

European Pharmaceutical Review

JUNE 2, 2023

The Centre for Process Innovation (CPI) is set to establish a new UK Intracellular Drug Delivery Centre to develop new lipid nanoparticle (LNP) formulations for RNA medicine delivery, and a framework to advance next-generation nano delivery systems.

Manufacturing 86

Manufacturing Medicine Training Networking 86

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What types of medicinal products are in short supply and why?

Pharmaceutical 94

Pharmaceutical Food and Drug Administration Transportation Manufacturing 94

Pharma Marketing Network

DECEMBER 21, 2020

Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e., Here are 5 considerations when developing a communications strategy for a novel genetic medicine. #1. Genetic literacy among clinicians may not be as high as you think. Creating a simple narrative is, of course, not simple.

Medicine 52

Medicine Marketing Pharmaceutical Education 52